Treatment of Disease by Modulation of SIRT6

H. Cohen; Yariv Kanfi; Sivan Elhanati

Treatment of Disease by Modulation of SIRT6

H. Cohen (Inventor), Yariv Kanfi (Inventor), Sivan Elhanati (Inventor)

The Mina and Everard Goodman Faculty of Life Sciences

Bar-Ilan University

Research output: Patent

Abstract

An aspect of an embodiment of the invention relates to providing treatment of disease, in particular age-related disease, through increasing or decreasing the activity of SIRT6 protein. This may be accomplished through upregulation and downregulation of expression of SIRT6 in mammals. It has been found by the inventors that mice over-expressing SIRT6 have a longer lifespan in comparison to control mice, indicating that increasing SIRT6 expression can lengthen lifespan of mammals. Agents which modulate SIRT6 expression through, for example binding to 3′UTR region of human mRNA encoding SIRT6 or by blocking binding of agents to 3′UTR region of human mRNA encoding SIRT6, have been identified.

Original language	American English
Patent number	9,422,561
State	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{a3c173d536fc4b1cae1efa4c1a85acb4,

title = "Treatment of Disease by Modulation of SIRT6",

abstract = "An aspect of an embodiment of the invention relates to providing treatment of disease, in particular age-related disease, through increasing or decreasing the activity of SIRT6 protein. This may be accomplished through upregulation and downregulation of expression of SIRT6 in mammals. It has been found by the inventors that mice over-expressing SIRT6 have a longer lifespan in comparison to control mice, indicating that increasing SIRT6 expression can lengthen lifespan of mammals. Agents which modulate SIRT6 expression through, for example binding to 3′UTR region of human mRNA encoding SIRT6 or by blocking binding of agents to 3′UTR region of human mRNA encoding SIRT6, have been identified.",

author = "H. Cohen and Yariv Kanfi and Sivan Elhanati",

year = "2016",

language = "American English",

publisher = "Washington, DC: U.S. Patent and Trademark Office",

type = "Patent",

note = "9,422,561",

}

TY - PAT

T1 - Treatment of Disease by Modulation of SIRT6

AU - Cohen, H.

AU - Kanfi, Yariv

AU - Elhanati, Sivan

PY - 2016

Y1 - 2016

N2 - An aspect of an embodiment of the invention relates to providing treatment of disease, in particular age-related disease, through increasing or decreasing the activity of SIRT6 protein. This may be accomplished through upregulation and downregulation of expression of SIRT6 in mammals. It has been found by the inventors that mice over-expressing SIRT6 have a longer lifespan in comparison to control mice, indicating that increasing SIRT6 expression can lengthen lifespan of mammals. Agents which modulate SIRT6 expression through, for example binding to 3′UTR region of human mRNA encoding SIRT6 or by blocking binding of agents to 3′UTR region of human mRNA encoding SIRT6, have been identified.

AB - An aspect of an embodiment of the invention relates to providing treatment of disease, in particular age-related disease, through increasing or decreasing the activity of SIRT6 protein. This may be accomplished through upregulation and downregulation of expression of SIRT6 in mammals. It has been found by the inventors that mice over-expressing SIRT6 have a longer lifespan in comparison to control mice, indicating that increasing SIRT6 expression can lengthen lifespan of mammals. Agents which modulate SIRT6 expression through, for example binding to 3′UTR region of human mRNA encoding SIRT6 or by blocking binding of agents to 3′UTR region of human mRNA encoding SIRT6, have been identified.

UR - https://scholar.google.co.il/scholar?q=Treatment+of+disease+by+modulation+of+sirt6&btnG=&hl=en&as_sdt=0%2C5

M3 - Patent

M1 - 9,422,561

PB - Washington, DC: U.S. Patent and Trademark Office

ER -

Treatment of Disease by Modulation of SIRT6

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this